A Brief Overview of Bergeniaciliata as a Potential Treatment for Liver Illness
1Department of Zoology, Branch Entomology, AbubakarTafawaBalewa University Bauchi, Nigeria.
2,3Department of Ecology, Branch Entomology, AbubakarTafawaBalewa University Bauchi, Nigeria
Citation: Ibrahim Friday Sule, Deda Gayi Kingsley, Ngeri Mark Adamu, “A Brief Overview of Bergeniaciliata as a Potential
Treatment for Liver Illness”, American Research Journal of Genetics, Vol 1, no. 1, 2022, pp. 14-19.
Abstract
Insulin resistance and oxidative stress are the primary contributors to the damage and loss of liver cells that occur in these
individuals. Researchers are looking at the potential benefits and applications of Bergeniaciliata for the very first time
in the context of the treatment of liver conditions. Bergeniaciliata, which is a member of the family Saxifragaceae and is
known for its adaptability, is regarded a wonder plant since it can be used in a variety of purposes. This piece of literature
contains an in-depth analysis as well as a summary of data obtained from a variety of sources located in India and all over
the globe. This research looks at scholarly publications such as journals and theses, as well as bibliographical databases
such as PubMed and Scopus. When B. ciliata was analyzed for its phytochemical composition, a variety of compounds,
including phenols, flavonoids, fatty acids, glycosides, and terpenoids, were found to be present. These are only some of
the chemicals. As a result of the existence of these bioactives, the B. ciliata plant as a whole may be used for a variety of
medical purposes. In addition to this, it is capable of reducing fever, fighting bacteria, and alleviating inflammation.
